Shiley-Marcos Alzheimer's Research Center

Shiley-Marcos Alzheimer's Research Center
Name	Shiley-Marcos Alzheimer's Research Center
Formed	1990s
Headquarters	San Diego, California
Parent organization	University of California, San Diego

Shiley-Marcos Alzheimer's Research Center is an academic research center affiliated with the University of California, San Diego focusing on Alzheimer's disease and related neurodegenerative disorders. The center integrates clinical care, basic neuroscience, translational research, and community outreach to advance diagnosis, treatment, and prevention strategies. It operates within a broader network of academic medical centers, biotechnology firms, philanthropic foundations, and government agencies.

History

The center was established during a period of expanding investment in Alzheimer's research alongside institutions such as Johns Hopkins University, Massachusetts Institute of Technology, Stanford University, Harvard Medical School, and Columbia University. Early leadership included investigators trained at National Institutes of Health, Mayo Clinic, and Scripps Research, building collaborations with the Alzheimer's Association, National Institute on Aging, and regional healthcare systems like Sharp HealthCare and Scripps Health. Over time the center has grown through philanthropic gifts from families and foundations similar to those supporting programs at Kaiser Permanente, Cleveland Clinic, and Mount Sinai Health System.

Mission and Research Focus

The center's mission emphasizes translational neuroscience, biomarker discovery, and therapeutic development akin to goals articulated by World Health Organization dementia initiatives and strategy documents from the Bill & Melinda Gates Foundation and Robert Wood Johnson Foundation. Research priorities include neuroimaging studies employing methods developed at University of California, Los Angeles and Yale University, genetic investigations referencing findings from Broad Institute consortia, and clinical trials modeled on protocols used at Fred Hutchinson Cancer Research Center and Vanderbilt University Medical Center. The program addresses neuropathological mechanisms described in reports by Alzheimer's Disease International and leverages standards from regulatory agencies like the Food and Drug Administration.

Clinical Programs and Patient Care

Clinical services provide memory assessment, cognitive neurology consultations, and caregiver support, aligning with practices at Mayo Clinic memory centers, Cleveland Clinic neurology departments, and outpatient programs at UCLA Health and Johns Hopkins Bayview Medical Center. The center participates in multicenter trials similar to those coordinated by Alzheimer's Disease Cooperative Study and engages with pharmaceutical partners including Biogen, Eli Lilly and Company, Roche, AstraZeneca, and Novartis for therapeutic trials. Patient registries and longitudinal cohorts are managed following models from Framingham Heart Study and consortiums like the Alzheimer's Disease Neuroimaging Initiative.

Research Facilities and Resources

Laboratory and imaging infrastructure includes magnetic resonance imaging facilities comparable to those at Massachusetts General Hospital and positron emission tomography capabilities used in studies at Mayo Clinic Arizona and University of Pennsylvania. Molecular biology, neuropathology, and biostatistics cores support work reminiscent of capabilities at Cold Spring Harbor Laboratory, Salk Institute, Scripps Research Institute, and Broad Institute. Data management and bioinformatics draw on platforms and standards developed by National Center for Biotechnology Information and collaborations with cloud resources used by Amazon Web Services in research partnerships.

Collaborations and Partnerships

The center maintains academic partnerships with institutions such as University of California, Los Angeles, University of Washington, Princeton University, Harvard University, Yale University, and University of Cambridge and industry collaborations with companies like Biogen, Roche, and Eli Lilly and Company. It engages with advocacy and funding organizations including the Alzheimer's Association, Alzheimer's Drug Discovery Foundation, Michael J. Fox Foundation for Parkinson's Research, and regional philanthropic contributors patterned after gifts from donors associated with The San Diego Foundation. Multicenter consortia involve networks similar to Alzheimer's Disease Neuroimaging Initiative, Global Alzheimer’s Platform Foundation, and international partners such as Karolinska Institutet and University College London.

Funding and Endowments

Support derives from federal grants from agencies like the National Institutes of Health, private philanthropy reflective of major gifts similar to those from the Gates Foundation and family foundations, competitive awards from the Alzheimer's Association, and sponsored research agreements with biotechnology and pharmaceutical firms including Biogen, Roche, Eisai, and Eli Lilly and Company. Endowment structures and named chairs follow models seen at Johns Hopkins University and Columbia University, and clinical trial funding mechanisms parallel those administered by the Patient-Centered Outcomes Research Institute.

Notable Research Contributions and Publications

Investigators at the center have contributed to studies on amyloid and tau pathophysiology, neuroimaging biomarker development, and genetic risk factors, publishing in journals and outlets such as Nature, Science, The New England Journal of Medicine, The Lancet, Neuron, and JAMA. Work has informed clinical guidelines promulgated by organizations like the American Academy of Neurology and has been cited in consensus reports from the National Institute on Aging and the World Health Organization. Collaborative publications have involved researchers affiliated with Massachusetts Institute of Technology, Stanford University, Harvard Medical School, Salk Institute, Broad Institute, University College London, Karolinska Institutet, Johns Hopkins University, and Yale University.

Category:Alzheimer's disease research institutes